A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection

NCT05467553 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Ursodeoxycholic acid
DRUG: Ropeginterferon alfa-2b
DRUG: Tenofovir Alafenamide

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]